Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | TOP1 | P11387 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25394654 | 1.00 | LMNA (0.58) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| SCHEMBL120420 | 1.00 | LMNA (0.58) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| SCHEMBL22961915 | 1.00 | LMNA (0.58) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| Ammonia Solution, Strong SCHEMBL30623262 | 0.97 | LMNA (0.55) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| SCHEMBL30459345 | 0.97 | LMNA (0.55) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| Bromide SCHEMBL25394898 | 0.97 | LMNA (0.55) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| Hydrochloric Acid SCHEMBL25395838 | 0.97 | LMNA (0.55) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| Ethylenediamine SCHEMBL7007237 | 0.91 | LMNA (0.48) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| Bicarbonate SCHEMBL20420640 | 0.85 | LMNA (0.57) | LMNAL3MBTL1TDP1TOP1KDM4E | |
| SCHEMBL21901457 | 0.84 | LMNA (0.58) | LMNAL3MBTL1TDP1TOP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4245293-B1 | USE OF SUGAR AMINES AS COMPLEXING AGENTS | CLARIANT INT LTD (CH) | 2025-08-06 | — | — | EP | disclosed |
| EP-4377368-B1 | AQUEOUS POLYURETHANE DISPERSION | ALLNEX AUSTRIA GMBH (AT) | 2025-06-18 | — | — | EP | disclosed |
| US-20240352178-A1 | AQUEOUS POLYURETHANE DISPERSION | ALLNEX AUSTRIA GMBH (AT) | 2024-10-24 | — | — | US | disclosed |
| EP-4400523-A1 | AQUEOUS POLYURETHANE-VINYL POLYMER HYBRID DISPERSION | Allnex Austria GmbH (AT) | 2024-07-17 | — | — | EP | disclosed |
| CN-117642443-A | Aqueous polyurethane dispersions | 湛新奥地利有限公司 | 2024-03-01 | — | — | CN | disclosed |
| EP-4286482-A1 | REMOVABLE WATER-BASED COATING | Glasst Innovation Company S.A.S. (CO) | 2023-12-06 | — | — | EP | disclosed |
| EP-4245293-A1 | USE OF SUGAR AMINES AS COMPLEXING AGENTS | Clariant International Ltd (CH) | 2023-09-20 | — | — | EP | disclosed |
| US-11760896-B2 | Water-based peelable coating | GLASST INNOVATION COMPANY S.A.S. (CO) | 2023-09-19 | — | — | US | disclosed |
| US-10736325-B2 | Surfactants and formulations | MONSANTO TECHNOLOGY LLC (US) | 2020-08-11 | — | — | US | disclosed |
| EP-3536385-A2 | HAIR TREATMENT COMPOSITION COMPRISING CARBOXYLIC ACID-N-ALKYLPOLYHYDROXYALKYLAMIDES | Clariant International Ltd (CH) | 2019-09-11 | — | — | EP | disclosed |
| US-7988950-B2 | Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (MRI) which contain a chelating moiety with polyhydroxylated substituents | BRACCO IMAGING S.P.A. (IT) | 2011-08-02 | — | — | US | disclosed |
| US-20110009641-A1 | Amine-containing lipids and uses thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-01-13 | — | — | US | disclosed |
| US-20100234228-A1 | NOVEL SURFACTANTS AND FORMULATIONS | MONSANTO TECHNOLOGY LLC (US) | 2010-09-16 | — | — | US | disclosed |
| EP-1765812-B1 | CONTRAST AGENTS ENDOWED WITH HIGH RELAXIVITY FOR USE IN MAGNETIC RESONANCE IMAGING (MRI) WHICH CONTAIN A CHELATING MOIETY WITH POLYHYDROXYLATED SUBSTITUENTS | BRACCO IMAGING SPA (IT) | 2009-04-29 | — | — | EP | disclosed |
| EP-1786475-B1 | 1,4-BIS(CARBOXYMETHYL)-6-[BIS(CARBOXYMETHYL)AMINO]-6-METHYL-PERHYDRO-1,4-DIAZEPINE (AAZTA) DERIVATIVES AS LIGANDS IN HIGH RELAXIVITY CONTRAST AGENTS FOR USE IN MAGNETIC RESONANCE IMAGING (MRI) | BRACCO IMAGING SPA (IT) | 2009-04-29 | — | — | EP | disclosed |
| US-20070258905-A1 | Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents | BRACCO IMAGING SPA (IT) | 2007-11-08 | — | — | US | disclosed |
| US-20070258905-A1 | Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents | BRACCO IMAGING SPA (IT) | 2007-11-08 | — | — | US | disclosed |
| US-20050282757-A1 | Peptide boronic acid compounds useful in anticoagulation | TRIGEN LIMITED | 2005-12-22 | — | — | US | disclosed |
| US-20050282757-A1 | Peptide boronic acid compounds useful in anticoagulation | TRIGEN LIMITED | 2005-12-22 | — | — | US | disclosed |
| US-20050164998-A1 | Steroid extraction process from urine sources | DR. REDDY'S LABORATORIES NEW YORK, INC. | 2005-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234228-A1 | NOVEL SURFACTANTS AND FORMULATIONS | PHOSPHO1, GNMT, DDT | LMNA 2033/4885L3MBTL1 2899/4885TDP1 810/4885 |
| US-20110009641-A1 | Amine-containing lipids and uses thereof | PHOSPHO1, CHMP4B, SGMS1 | LMNA 402/4885L3MBTL1 1790/4885TDP1 1468/4885 |
| US-20050282757-A1 | Peptide boronic acid compounds useful in anticoagulation | SERPINC1, HABP2, F11 | LMNA 901/4885L3MBTL1 224/4885TDP1 310/4885 |
| US-10736325-B2 | Surfactants and formulations | PHOSPHO1, GNMT, DDT | LMNA 1242/4885L3MBTL1 2671/4885TDP1 804/4885 |
| US-20070258905-A1 | Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents | RXFP1, SLC5A7, SLC40A1 | LMNA 3144/4885L3MBTL1 2173/4885TDP1 1659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.